-
Mashup Score: 59A New Vaccine to Target Treatment-Resistant Glioblastoma - 6 month(s) ago
Image
Source: ccr.cancer.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 8CCR researchers receive a range of HHS awards - 7 month(s) ago
Three CCR researchers received prestigious awards from the Department of Health and Human Services. They are being recognized for their excellence, dedication and achievements in their respective research fields.
Source: ccr.cancer.govCategories: General Medicine News, Hem/OncsTweet-
RT @NCIDirector: Congrats to these 3 outstanding @theNCI researchers honored by @HHSGov! 👏 https://t.co/5GZcWc91u0 ▪️️ Marston Linehan: Sec…
-
-
Mashup Score: 27Study sheds light on diversity of study participants at CCR - 7 month(s) ago
Diversity in clinical trials is critical for understanding how well a treatment may work in different populations. A new study describes representation based on sex, age and ethnicity in clinical trials done at CCR.
Source: ccr.cancer.govCategories: General Medicine News, Onc News and JournalsTweet-
Diversity in clinical trials is critical for understanding how well a treatment may work in different populations. A new study describes the representation of various population groups in trials done at NCI’s Center for Cancer Research. @NCIResearchCtr https://t.co/jkxg8BXVPD
-
-
Mashup Score: 19Goodbye Lymphomatoid Granulomatosis | Center for Cancer Research - 7 month(s) ago
A clinical trial that has been running for 30 years leads to a highly effective treatment for the rare precancerous condition lymphomatoid granulomatosis.
Source: ccr.cancer.govCategories: General Medicine News, Onc News and JournalsTweet-
A 30-year clinical trial has led to a highly effective treatment for lymphomatoid granulomatosis, a rare and life-threatening disease that affects the immune system. Learn more: https://t.co/9oe9zUZfCA @NCIResearchCtr #RareCancer #CancerResearch https://t.co/r6eQbYYp1N
-
-
Mashup Score: 28No Point of No Return | Center for Cancer Research - 7 month(s) ago
Overturning a long-held dogma of how cells grow and divide, it turns out cells can reverse their decision to undergo mitosis, or cell division, later in the process than previously thought.
Source: ccr.cancer.govCategories: General Medicine News, Onc News and JournalsTweet-
A new view of cell division could change the way scientists think about how some cancer drugs impact cells. Learn more about the research: https://t.co/f1IL36vpSO @NCIResearchCtr #CancerTreatments #CancerResearch https://t.co/b35dsfLKPc
-
-
Mashup Score: 44New biomaterial enhances cancer vaccine effectiveness to help eliminate cancer in mice - 7 month(s) ago
Scientists have created a new type of cancer vaccine approach that uses a biomaterial that attracts immune cells and localizes the delivery of the vaccines. In mice, the biomaterial combined with a cancer vaccine was able to cure 50 to 75% of their tumors.
Source: ccr.cancer.govCategories: General Medicine News, Onc News and JournalsTweet-
Researchers have developed a biomaterial that, when combined with a cancer vaccine, substantially boosts the effectiveness of the vaccine. The approach was able to eliminate tumors in more than half of the mice studied. @NCIResearchCtr https://t.co/onQnUy0YRd #CancerTreatment
-
-
Mashup Score: 14Two Strikes Against Mesothelioma | Center for Cancer Research - 7 month(s) ago
One study identified gene signatures associated with mesothelioma outcomes and responses to treatment, and a clinical trial showed that mesothelioma can be treated with adoptive T-cell therapy.
Source: ccr.cancer.govCategories: General Medicine News, Onc News and JournalsTweet-
Two new studies describe advances against mesothelioma, an aggressive tumor that affects the lining of the lungs or the abdomen. Learn more about the research: https://t.co/jZMFhjTJhL @NCIResearchCtr #Mesothelioma #CancerResearch https://t.co/aRjlc98x9j
-
-
Mashup Score: 9Learning from Our Pets | Center for Cancer Research - 7 month(s) ago
Studying osteosarcoma in dogs may improve treatment options for people and pets.
Source: ccr.cancer.govCategories: General Medicine News, Onc News and JournalsTweet-
#Osteosarcoma is an aggressive bone cancer that occurs in dogs and people. New research involving studies of pet dogs with the cancer suggests potential strategies for treating both 4-legged and 2-legged patients. @NCIResearchCtr https://t.co/B6uU0FXxMg #NationalPetDay https://t.co/3gk44JEwMn
-
-
Mashup Score: 26Director's Note | Center for Cancer Research - 7 month(s) ago
Center for Cancer Research Director Tom Misteli discusses how new cancer treatments result from many different types of basic and clinical research fitting together like a puzzle.
Source: ccr.cancer.govCategories: General Medicine News, Onc News and JournalsTweet-
"Cancer research comes in different flavors," notes Dr. Tom Misteli of @NCIResearchCtr. Check out the new issue of Milestones magazine to read about scientific advances from the past year." https://t.co/hKBsxAgSbx #CancerDetection #CancerTreatment #CancerMoonshot
-
-
Mashup Score: 13CCR Milestones - 2024 | Center for Cancer Research - 8 month(s) ago
Check out Milestones 2024, CCR’s annual review of research highlights.
Source: ccr.cancer.govCategories: General Medicine News, Onc News and JournalsTweet-
Check out the top scientific advances from the past year in the newest edition of Milestones from NCI's Center for Cancer Research! https://t.co/KsIWAU3JCC #CancerPreventionandEarlyDetectionMonth #CancerTreatment https://t.co/Bsa02Gj39r
-
NCI researchers have tested in mice a cancer vaccine that can activate immune cells to recognize and attack a brain tumor called #glioblastoma. Learn more: https://t.co/gYa1mSAWVW #BTAM #NationalCancerResearchMonth @NCIResearchCtr https://t.co/cmCdZwBiOR